Skip to main content
Journal cover image

Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment

Publication ,  Journal Article
Tcheng, J; Mann, H; London, AJ; Mann, J
Published in: Clinical Trials
July 13, 2005

Duke Scholars

Published In

Clinical Trials

ISSN

1740-7745

Publication Date

July 13, 2005

Volume

2

Issue

3

Start / End Page

242 / 243

Related Subject Headings

  • Statistics & Probability
  • 5203 Clinical and health psychology
  • 4905 Statistics
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
  • 0104 Statistics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tcheng, J., Mann, H., London, A. J., & Mann, J. (2005). Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment. Clinical Trials, 2(3), 242–243.
Tcheng, J., H. Mann, A. J. London, and J. Mann. “Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment.” Clinical Trials 2, no. 3 (July 13, 2005): 242–43.
Journal cover image

Published In

Clinical Trials

ISSN

1740-7745

Publication Date

July 13, 2005

Volume

2

Issue

3

Start / End Page

242 / 243

Related Subject Headings

  • Statistics & Probability
  • 5203 Clinical and health psychology
  • 4905 Statistics
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
  • 0104 Statistics